MedTrace Logo

Registry of Subjects With Drug Resistant Epilepsy and Treated With the VNS Therapy System.

NCT03529045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 827

Last updated 2024-11-22

No results posted yet for this study

Summary

Multicenter global post-market registry of subjects diagnosed with drug resistant epilepsy and treated with the VNS Therapy System.

Conditions

Interventions

DEVICE

Vagus Nerve Stimulation (VNS) Therapy

The VNS Therapy System is a commercially available device that will be used by licensed medical practitioners trained in the use of VNS Therapy, per the practitioners' medical judgement.

Sponsors & Collaborators

  • LivaNova

    lead INDUSTRY

Principal Investigators

  • Jeffrey Way · LivaNova, Inc.

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-02-05
Primary Completion
2024-09-11
Completion
2024-09-11
FDA Device
Yes

Countries

  • United States
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Canada
  • China
  • India
  • Israel
  • Italy
  • Japan
  • Netherlands
  • Poland
  • Portugal
  • Saudi Arabia
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03529045 on ClinicalTrials.gov